NATCO PHARMA LIMITED (INDIA)
Ceritinib-noxalk
"Ceritinib" is the Drug / Molecule content in "Noxalk". It is an anaplastic lymphoma kinase (ALK) positive inhibitor primarily used for the treatment of metastatic NSCLC. Noxalk thus acts to inhibit mutated enzyme and stop cell proliferation, ultimately halting cancer progression.
Indication
Ceritinib is used for the treatment of non-small cell lung cancer.
Note
Precaution
- Ceritinib is a prescription drug and should be used under proper medical guidance and advice.
- Ceritinib may cause severe, life-threatening or fatal interstitial lung disease / pneumonitis
Strength
150 mg
Packing
1 X 30 Capsules & 1 X 90 Capsules (Bottle)
Storage
Store at room Temperature (25°C).
Was this page helpful?
Related Products
CIPLA LTD. (INDIA)
Pirfenex
NATCO PHARMA LIMITED (INDIA)
Erlonat
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Gefitinib-geftinat
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)